Evangelia-Alexandra Salvanou

Synthesis and In Vitro Evaluation of Gold Nanoparticles Functionalized with Thiol Ligands for Robust Radiolabeling with 99mTc

P. Bouziotis, A. Chiotellis, M. Paravatou‐Petsotas, 2021, Nanomaterials.

Synthesis and in vitro proof-of-concept studies on bispecific iron oxide magnetic nanoparticles targeting PSMA and GRP receptors for PET/MR imaging of prostate cancer.

Christos Liolios, A. Kolocouris, E. Efthimiadou, 2022, International journal of pharmaceutics.

Preliminary Evaluation of Iron Oxide Nanoparticles Radiolabeled with 68Ga and 177Lu as Potential Theranostic Agents

Christos Liolios, A. Kolokithas-Ntoukas, K. Avgoustakis, 2022, Nanomaterials.

Biodistribution of Mesoporous Carbon Nanoparticles via Technetium-99m Radiolabelling after Oral Administration to Mice

G. Charalambopoulou, T. Steriotis, D. Giasafaki, 2021, Nanomaterials.

Chelator-Free/Chelator-Mediated Radiolabeling of Colloidally Stabilized Iron Oxide Nanoparticles for Biomedical Imaging

M. Gazouli, A. Bakandritsos, A. Kolokithas-Ntoukas, 2021, Nanomaterials.

Radiolabeled Nanoparticles in Nuclear Oncology

P. Bouziotis, Evangelia-Alexandra Salvanou, C. Tsoukalas, 2018 .

Old Drug, New Delivery Strategy: MMAE Repackaged

F. Rösch, P. Bouziotis, Evangelia-Alexandra Salvanou, 2023, International journal of molecular sciences.

A Proof-of-Concept Study on the Therapeutic Potential of Au Nanoparticles Radiolabeled with the Alpha-Emitter Actinium-225

R. Bazzi, S. Roux, F. Denat, 2020, Pharmaceutics.

Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancer

Christos Liolios, P. Bouziotis, Evangelia-Alexandra Salvanou, 2023, Frontiers in Nuclear Medicine.